Therapeutic effect of sarpogrelate, a new 5-hydroxytryptamine receptor 2A antagonist, on diabetic nephropathy and neuropathy.

Source:http://linkedlifedata.com/resource/pubmed/id/9200418

Download in:

View as

General Info

PMID
9200418